Pharmaceutical Intelligence Enters Open Source Era

drug-pipeline-mcp consolidates scattered pharmaceutical R&D data—from clinical trials to FDA approvals and patent records—into a single AI-accessible platform, breaking down information barriers that previously favored industry insiders. This democratization enables rapid drug pipeline analysis and evidence-based decision-making in biotech investment and research prioritization. The open-source release reflects a growing trend of AI tools breaking down data silos in regulated industries, reshaping how pharmaceutical companies and researchers access critical intelligence.